Green Cross Holdings Corporation (KRX:005257)

South Korea flag South Korea · Delayed Price · Currency is KRW
25,500
+350 (1.39%)
At close: Nov 4, 2025
1.39%
Market Cap725.07B
Revenue (ttm)2.27T
Net Income (ttm)117.43B
Shares Outn/a
EPS (ttm)2,586.53
PE Ratio6.17
Forward PEn/a
Dividend500.00 (1.96%)
Ex-Dividend DateDec 27, 2024
Volume1,082
Average Volume1,162
Open25,150
Previous Close25,150
Day's Range25,150 - 26,200
52-Week Range18,300 - 73,900
Beta1.07
RSI38.06
Earnings DateNov 14, 2025

About Green Cross Holdings

Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1967
Employees 144
Stock Exchange Korea Stock Exchange
Ticker Symbol 005257
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.